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ABSTRACT 
Background: Asphyxia is a medical situation resulting from the deprivation of oxygen to a newborn lasting long 
enough during the birth process to cause physical harm, especially to the brain. Human umbilical cord blood (UCB) is a 
well-established source of hematopoietic stem/progenitor cells (HSPCs) for allogeneic stem cell transplantation. A low 
level of O2 in neonates with asphyxia during labor can affect proliferation and differentiation of stem cells in cord 
blood. 
Methods: The quality and colony-forming ability of hematopoietic stem cells in the cord blood of neonates with severe 
asphyxia with Apgar score 3-5or need to cardiac pulmonary resuscitation 5 min after delivery were compared with the 
group with normal Apgar score. Thereafter, hematopoietic stem cells were isolated, and cells were cultured in an 
enriched media (MethoCult H4435) special for HSPCs for 7 days to assess the growth and colony formation.  
Results: Based on the results, there was a significant difference in the number of colonies of RBC (P=0.0016) and WBC 
precursor (P=0.006), in a plate with 104 cord blood hematopoietic stem cells in newborns exposed to hypoxemia 
during labor. 
Conclusion: Umbilical cord blood is valuable for its content of stem cells. Severe hypoxia in the perinatal period does 
not negatively affect the viability of UCB-derived HSPCs to grow and form colonies. Furthermore, it was found that 
transient severe asphyxia does not exert negative effects on the banking quality of HSPCs for likely problems in the 
future. 
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Introduction 
Asphyxia which is a major cause of neonatal 
mortality and neurological problems (1) is defined 
as a mixture of hypoxemia (oxygen deficiency 
in arterial blood), hypercapnia (a condition of 
abnormally elevated carbon dioxide (CO2) levels 
in the blood), and metabolic acidemia. Apgar score 
is one of the main criteria suggesting severe 
asphyxia. Although the majority of these disorders 
are transient, severe cases of asphyxia lead to 
hypoxic-ischemic encephalopathy (HIE) which 
occasionally results in permanent neurological 
damage, which can finally lead to cerebral palsy, 
epilepsy, and learning disabilities (2, 3).  
Umbilical cord blood (UCB) stem cells were 
historically considered an unused product of the 
birthing process but are now known to have more 
stem cells than adult bone marrow. When UCB is 
selected for therapeutic use, acute reactions in the 
host are really low, in comparison with other 
sources of stem cells, such as Bone Marrow Stem 
Cells (BMSCs) (4, 5). Autologous intravenous UCB 
transplantation is safe and possible in young 
children with acquired neurological disorders,  
and UCB transplantation recovers sensorimotor 
deficiencies after HIE (6). 
Stem cells, such as hematopoietic stem and 
progenitor cells (HSPCs) are really sensitive to 
oxygen pressure levels and hypoxia. In other 
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words, the low level of oxygen plays a key role in 
the regulation of stem cells and their fate (7). 
Expansion and function of the hematopoietic 
system, self-renewal and maintenance of 
embryonic stem cells, and differentiation capacity 
of mesenchymal stem cells (MSCs) are under the 
influence of the Hypoxia-induced factor (HIF) 
mechanism (8-12). Scientists have demonstrated 
that when HSPCs are cultured at reduced oxygen 
pressure, they enhance the potential of self-
renewal and in vitro expansion (13-16). Moreover, 
hypoxia can affect the expansion of MSCs derived 
from bone marrow, UCB, and amniotic fluid (17). 
The MSCs which are derived from UC regulate 
energy consumption and metabolism during 
hypoxia, and hypoxia leads to an increase in the 
growth of UC-derived MSCs. The incubation of UC- 
derived MSCs at various concentrations of oxygen 
led to a rise in cell proliferation at hypoxia 
conditions (18). 
UCB is a potentially vast precursor of HSPCs 
for hematopoietic reconstitution which can be 
clinically used as a reliable alternative for bone 
marrow transplantation in adults and pediatrics. 
Serious hematological malignancies, such as 
sickle cell disorders, leukemia, thalassemia 
immunological defects, bone marrow failure, as 
well as genetic diseases, have been considerably 
treated with cord blood (19-27). Since the first cord 
blood transplantation in 1988(28), more than 
25,000 allogeneic cord blood transplantations 
(ACBT) have been globally performed, and their 
results can be compared with the bone marrow as 
the donor source for transplantations(29). These 
achievements demonstrate the role of UCB cells in 
the treatment of human diseases(30).  
Today, more than 20% of states in the USA 
are involved in educating residents about the 
importance of UCB banking and its clinical 
benefits. Therefore, UCB banking for autologous 
and/or allogeneic transplantation and other 
ongoing purposes seems necessary. To 
demonstrate the quality of HSPCs exposed to 
transient severe hypoxia condition during labor 
by evaluating the HSPCs colony-forming 
efficiency, the present study aimed to assess 
whether primary hypoxia can affect the 
properties and abilities of HSPCs for making 
colonies even after culture in a normoxia 





The current study was conducted on 11 
neonates as the asphyxia group (umbilical blood 
gases measured, Apgar score 3-5) and 10 normal 
newborns with more than 8 Apgar score as a 
normal group. The exclusion criteria for normal 
neonates were any diseases or anomalies, and 
the exclusion criteria for the asphyxia group was 
Apgar score more than 5 without severe hypoxia 
condition. The written informed consent was 
obtained from neonates' parents before 
participating in the research project. It is 
noteworthy that this study was confirmed by the 
Ethical Committee of Mashhad University of 
Medical Sciences. 
 
Blood samples  
Umbilical cord blood cells were collected from 
the Maternity ward of Imam Reza Hospital, 
Mashhad, Iran, within November 2014-May 2015. 
The umbilical cord with 6-8 cm extent of the 
umbilicus and other side was tied and transected 
between both sides 5 min after delivery. Blood 
was collected from the placenta end of the cord or 
by needle aspiration of the removed placenta. 15-
25cc cord blood was collected and mixed with  
5-6cc citrate anticoagulant (Citrate-dextrose 
solution- C3821-Sigma-Aldrich). The maximum 
elapsed time for transporting the samples to the 
clean room of the stem cell laboratory was 30 min, 
and they were transferred to sterile conditions. 
 
Methods 
Depending on the sample size, 5-7cc 
Hydroxyethyl starch 10% (HES 200/0.5) 
(Fresenius Kabi, 14CA7310) was added to each 
sample and shacked vigorously. For efficient cell 
separation and red blood cell (RBC) precipitation 
by HES, the immobilized samples were placed in a 
sterile laminar class II cabinet. After 1 h, the 
supernatant was removed by sterile syringe and 
centrifuged at 600 g at 25oC for 20 min. The 
progenitor cells were placed on a buffy coat layer 
which was precisely separated by a needle 
immediately after centrifugation. To achieve the 
required concentrations of progenitor cells, they 
were counted by trypan blue Neubauer slide (31). 
Moreover, samples were evaluated by a cell 
counter (Sysmex XP300, USA) for further 
investigation.  
In 12-well plates, 1ml of medium special for 
HSPCs (MethoCult H 4435 enriched, 04445, stem 
cell technology) (32), along with 104 progenitor 
cells obtained from buffy coat layer, was plated 
and 2 wells were cultured with double progenitor 
cell concentration. The cultured samples were 
incubated at 37oC, 85% humidity, and 5% CO2 for  
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Figure 1. A. Red blood cell (erythrocyte) progenitor colonies (×100). B: Separated white blood cell (leukocyte) progenitor colonies 
(×400). C: white blood cell progenitor colonies (×100) 
 
7 days based on our instruction (Colony 
Identification Guide) (33) and previous results. 
After incubation time, the colonies were counted 
by an inverted microscope. All the calculated cells 
were alive. Red colonies were regarded as red 
blood cell precursors, and white colonies were 
considered white blood cell precursors(Figure 1). 
  
Statistics 
The collected data were analyzed in GraphPad 
Prism software (version 3) using the unpaired t-
test. The significance level was considered less 
than 0.05 with a confidence interval of 95 %.  
 
Results 
The mean number of colonies of white blood 
cell precursors in cord blood of neonates with 
asphyxia exposed to hypoxia was obtained at 
40.72±7.9 in culture media for 7 days, while it was 
reported as 15.5±2.3 in newborns without 
asphyxia; therefore the difference was significant 





































Graph 1. Number of colonies of WBC precursors in cord blood 
after the culture cells for 7 days in H4435 culture media was 
significant in neonates exposed to hypoxia following asphyxia, 




































Graph 2. Significant difference of colonies of RBC precursors in 
cord blood in two groups of neonates after culture cells in 
H4435 culture media for 7 days (P-value=0.0019) 
 
the independent T-Test showed a significant 
difference in the mean number of colonies of red 
blood cell precursors (red colonies) in cultured 
media for the newborns who were exposed to 
hypoxemia(66.2±10.65), compared to healthy 
neonates (16.34±5.1; P=0.001; Graph 2).  
 
Discussion 
As evidenced by the results of the current 
study, hypoxia which results from low oxygen 
pressure in newborns with asphyxia increased 
the colony-forming efficiency of HSPCs in in vitro 
study. Hypoxia is one of the most important 
environmental factors affecting cells in various 
ways. Hypoxia plays a significant role in different 
features of cell biogenesis, such as metabolism, 
migration, proliferation, and differentiation. In 
the current research, the obtained results 
demonstrated that hypoxia in neonates with 
asphyxia increased the ability of HSPCs to form 
colonies and did not exert negative effects on the 
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viability and quality of HSPCs in culture media. 
Therefore, to the best of our knowledge, banking 
of cord blood of neonates with asphyxia and 
severe hypoxia poses no problem for therapeutic 
purposes in the future. 
The obtained data demonstrated that the 
colony-forming efficiency of RBC and WBC 
precursors significantly increased in the UCB of 
neonates born with asphyxia, in comparison to the 
normal group. Based on the study conducted by 
Sushmita Roy et al., higher oxygen pressure has 
potentially been destructive on UCB-derived 
HSPCs, whereas the proliferation of UCB-derived 
HSPCs enhanced significantly under hypoxic 
conditions (15). We observed a 2.62-fold 
increase in the colony-forming efficiency of WBC 
progenitors, while that of RBC precursors was 
elevated 4 folds in UCB-HSPCs of neonates with 
Apgar 5 and less, while Roy et al. showed a 27-
fold expansion in HSCs under hypoxic condition. 
Grayson et al. indicated that MSCs and HSPCs 
have progressive growth under 5% O2 during 
culture, and total cell numbers were induced in 
serial passages (34). Different studies showed that 
using low oxygen levels has significant effects on 
cell proliferation (35, 36). Embryonic stem cells 
have better growth and more proliferation in low 
levels of oxygen, compared to room air. Numerous 
investigations have demonstrated that in asphyxia 
conditions, the nucleated red blood cells (NRBC) 
were significantly more than the control group 
(37-39).  
The present study demonstrated that 7-day 
incubation in 80% humidity, 37oC, and 5% carbon 
dioxide provides the most appropriate condition 
for UCB-derived HSPCs. Based on our observation, 
after 16 days of incubation, more than half of  
the expanded colonies showed signs of cell 
degeneration, and almost all colonies were 
completely destroyed when the incubation 
continued beyond 20 days. Our represented 
observations were in agreement with the study 
performed by Nakahata and Ogawa. They showed 
that when culture condition is sustained more 
than 16 days, some colonies were totally 
disintegrated, and on day 25 after seeding, just 
four types of colonies were recognizable (33).  
The current study aimed to show that asphyxia 
has no negative effects on UCB banking; 
nonetheless, it was observed that the hypoxia 
caused by asphyxia significantly improved the 
colony-forming efficiency of UCB-derived HSPCs. 
On the other hand, oxygen levels are really 
important in the proliferation and differentiation 
of stem cell populations, especially HSPCs (40-43). 
Low oxygen level has been reported to stimulate 
quiescence and adjust their differentiation, 
thereby maintaining stem cell phenotype. Even 
very low oxygen concentrations are permissive for 
slow self-renewing divisions of hematopoietic 
stem cells (44-47) 
The current pilot study was conducted on 
limited samples obtained from one hospital; 
therefore, it is suggested that future studies be 
performed on a complicated population. In fact, 
the use of transplants of UCB over BMSCs has 
some advantages, such as ease of collection, no 
risk for mother and neonate, less time needed for 
processing, less risk for infection transmission, 




As evidenced by the obtained results, UCB is 
valuable for its content of stem cells. There is 
growing interest in the use of cord blood for novel 
indications in regenerative therapy and repair of 
neurological conditions, including cerebral palsy. 
Preserving UCB in public and/or private banks is 
beneficial for every family. The findings of the 
present study can raise public awareness about 
the positive outcomes of using cord blood 
banking. In brief, the obtained results indicated 
that transient severe asphyxia did not negatively 
affect the banking ability of HSPCs for likely 
problems in the future. 
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